MeCure Industries Plc has announced the successful acquisition of a 10% equity stake in the company by Zrosk Investment Management Ltd.
According to the disclosure, the transaction was conducted off-market and has since been finalized with approval from the NGX, officially making Zrosk Investment a key shareholder in MeCure.
The investment will reinforce MeCure’s financial foundation and fast-track its growth strategy, positioning the company for expanded operations within Nigeria’s pharmaceutical and healthcare sectors.
MeCure CEO, Arjun Udani, welcomed Zrosk Investment Management Ltd.
as a significant shareholder, remarking:“This investment highlights the confidence in our long-term vision and our commitment to providing quality healthcare solutions for millions of Nigerians.
MeCure’s PerformanceBased in Lagos, MeCure is one of the leading players in Nigeria’s pharmaceutical sector.
..
News articles remains the property of the source. Tellbrief is a news aggregator.
